Vol 2 Issue 5

CELL AND GENE THERAPY INSIGHTS

Vol 2 Issue 5

Cell and Gene Therapy Insights Vol 2 Issue 5

Download PDF

Featuring

Issue Spotlight: Gene Therapy Viral Vectors: Advances and Challenges
Other articles

Gene Therapy Viral Vectors: Advances and Challenges

Axel Schambach

Guest Editor:

Axel Schambach, Head, Institute of Experimental Hematology at Hannover Medical School

Editorial

Clinical translation of viral vectors for gene therapies and beyond

Clinical translation of viral vectors for gene therapies and beyond

Gerhard Bauer, Mohamed Abou-El-Enein

5 December 2016

AAV vector and gene therapy: en route for the American dream?

AAV vector and gene therapy: en route for the American dream?

Nathalie Clement

5 December 2016

Expert Insight

Advances and challenges in the use of recombinant AAV vectors for human gene therapy

Advances and challenges in the use of recombinant AAV vectors for human gene therapy

Arun Srivastava

5 December 2016

Repurposing lentiviral vectors for delivery of genome editing tool kits

Repurposing lentiviral vectors for delivery of genome editing tool kits

Jacob Giehm Mikkelsen

5 December 2016

Mouse mammary tumor virus-based vector for efficient & safe transgene delivery into mitotic & non-mitotic cells

Mouse mammary tumor virus-based vector for efficient & safe transgene delivery into mitotic & non-mitotic cells

Stanislav Indik

5 December 2016

Review

AAV vector production: state of the art developments and remaining challenges

AAV vector production: state of the art developments and remaining challenges

Otto-Wilhelm Merten

5 December 2016

Innovator Insight

Continuous flow centrifugation: importance in vector scale up

Continuous flow centrifugation: importance in vector scale up

Sandra Merino, Scott Glanzman

5 December 2016

Interview

State of the art lentiviral vector manufacturing

State of the art lentiviral vector manufacturing

5 December 2016

Foamy virus: an emerging viral vector for human gene therapy

Foamy virus: an emerging viral vector for human gene therapy

5 December 2016

Alpharetroviral self-inactivating vectors: an emerging tool for gene therapy

Alpharetroviral self-inactivating vectors: an emerging tool for gene therapy

5 December 2016

Journal articles

Expert Roundtable Video

Developments in the use of ESCs for cardiovascular disease – Elisa Manzotti talks with Prof. Philippe Menasche

Developments in the use of ESCs for cardiovascular disease – Elisa Manzotti talks with Prof. Philippe Menasche